Semen treatment with progesterone and/or acetyl-L-carnitine does not improve sperm motility or membrane damage after cryopreservation-thawing

Fertil Steril. 2000 Oct;74(4):715-20. doi: 10.1016/s0015-0282(00)01494-1.

Abstract

Objective: To assess the effects of progesterone and acetyl-L-carnitine used before semen cryopreservation-thawing on sperm motility parameters and plasma membrane integrity.

Design: Prospective cohort study.

Setting: Academic tertiary center.

Patient(s): Subfertile men undergoing semen evaluation.

Intervention(s): Before cryopreservation, spermatozoa were incubated with water-soluble progesterone (1 and 10 microM), acetyl-L-carnitine (2.5, 5, 10, and 20 mM), or both (progesterone, 1 microM; and acetyl-L-carnitine, 5 mM).

Main outcome measure(s): Postthaw change of motility parameters (computer-assisted measurements) and vitality-membrane integrity (examined with eosin-Y staining and annexin V-Cy3 binding assay).

Result(s): There were no statistically significant differences between control samples and samples treated with progesterone and/or acetyl-L-carnitine for cryosurvival rate, motility parameters, or membrane integrity. The percentages of postthaw cells identified as live showed significantly different results with use of the eosin-Y staining and annexin V binding assay.

Conclusion(s): Neither progesterone nor acetyl-L-carnitine seemed to prevent cryodamage assessed by motility changes or membrane integrity in human spermatozoa of subfertile men. Annexin V binding, a reflection of membrane translocation of phosphatidylserine, provided more distinct information about postfreezing membrane integrity changes than eosin-Y staining.

Publication types

  • Clinical Trial

MeSH terms

  • Acetylcarnitine / therapeutic use*
  • Annexin A5 / metabolism
  • Apoptosis
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cohort Studies
  • Cryopreservation*
  • Eosine Yellowish-(YS)
  • Fluorescent Dyes
  • Humans
  • Infertility, Male / drug therapy*
  • Infertility, Male / physiopathology
  • Male
  • Outcome Assessment, Health Care
  • Phosphatidylserines / metabolism
  • Progesterone / therapeutic use*
  • Prospective Studies
  • Semen / drug effects*
  • Semen Preservation / methods*
  • Sperm Motility / drug effects*

Substances

  • Annexin A5
  • Fluorescent Dyes
  • Phosphatidylserines
  • Progesterone
  • Acetylcarnitine
  • Eosine Yellowish-(YS)